Literature DB >> 20408338

Factors that affect the allergic rhinitis response to ragweed allergen exposure.

Anne K Ellis1, Jodan D Ratz, Andrew G Day, James H Day.   

Abstract

BACKGROUND: People with seasonal allergic rhinitis (SAR) respond to allergen exposure differently.
OBJECTIVE: To determine the factors that affect the rate and degree of symptom development upon controlled allergen exposure.
METHODS: Study participants underwent skin prick testing (SPT) to selected aeroallergens, completed the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) and the 36-Item Short Form Health Survey, and provided a detailed allergy and exposure history. Nasal eosinophil counts and late-phase responses to SPT were measured. Eligible participants underwent a 3-hour ragweed pollen exposure in the Environmental Exposure Unit, rating rhinoconjunctivitis symptoms every 30 minutes. Data were analyzed using a mixed-effects model for repeated measures.
RESULTS: One hundred twenty-three participants completed the study. Skin test reactivity to ragweed was not correlated with the rate of symptom development or with severity. Participants with positive SPT reactions to dust mite, dog, or grass and those with self-reported symptoms to dog or cat exposure tended to develop symptoms earlier and to a greater degree by 90 minutes. Self-report of SAR symptoms during the ragweed or grass season and RQLQ scores were positively associated with the rate and degree of symptom development. No other significant associations were detected.
CONCLUSIONS: The rate of symptom development upon ragweed exposure was related to concomitant hypersensitivity to perennial allergens and grass pollen as determined by SPT and clinical history. The RQLQ was a powerful predictor of the priming response to ragweed, showing a dose-response-type association. These data suggest that a "prepriming" phenomenon is present in patients with SAR. No correlation was shown between symptomatic responses and degree of SPT reactivity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20408338     DOI: 10.1016/j.anai.2010.01.012

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  14 in total

Review 1.  Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research.

Authors:  Michelle L North; Mena Soliman; Terry Walker; Lisa M Steacy; Anne K Ellis
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

Review 2.  The Clinical Utility of Pollen Counts.

Authors:  Carmi Geller-Bernstein; Jay M Portnoy
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

3.  Sublingual immunotherapy: World Allergy Organization position paper 2013 update.

Authors:  Giorgio Walter Canonica; Linda Cox; Ruby Pawankar; Carlos E Baena-Cagnani; Michael Blaiss; Sergio Bonini; Jean Bousquet; Moises Calderón; Enrico Compalati; Stephen R Durham; Roy Gerth van Wijk; Désirée Larenas-Linnemann; Harold Nelson; Giovanni Passalacqua; Oliver Pfaar; Nelson Rosário; Dermot Ryan; Lanny Rosenwasser; Peter Schmid-Grendelmeier; Gianenrico Senna; Erkka Valovirta; Hugo Van Bever; Pakit Vichyanond; Ulrich Wahn; Osman Yusuf
Journal:  World Allergy Organ J       Date:  2014-03-28       Impact factor: 4.084

4.  Seasonal variation in skin sensitivity to aeroallergens.

Authors:  Inseon S Choi; Seung-Sin Lee; Eun Myeong; Jeong-Won Lee; Woo-Jin Kim; Joon Jin
Journal:  Allergy Asthma Immunol Res       Date:  2013-08-07       Impact factor: 5.764

5.  Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit.

Authors:  Michelle L North; Terry J Walker; Lisa M Steacy; Barnaby G Hobsbawn; Richard J Allan; Frances Hackman; Xiaoqun Sun; Andrew G Day; Anne K Ellis
Journal:  Allergy Asthma Clin Immunol       Date:  2014-07-03       Impact factor: 3.406

6.  Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU).

Authors:  Anne K Ellis; Lisa M Steacy; Barnaby Hobsbawn; Caroline E Conway; Terry Jb Walker
Journal:  Allergy Asthma Clin Immunol       Date:  2015-01-27       Impact factor: 3.406

7.  A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis.

Authors:  Anne K Ellis; Yifei Zhu; Lisa M Steacy; Terry Walker; James H Day
Journal:  Allergy Asthma Clin Immunol       Date:  2013-05-01       Impact factor: 3.406

8.  The connection of pollen concentrations and crowd-sourced symptom data: new insights from daily and seasonal symptom load index data from 2013 to 2017 in Vienna.

Authors:  Katharina Bastl; Maximilian Kmenta; Markus Berger; Uwe Berger
Journal:  World Allergy Organ J       Date:  2018-10-16       Impact factor: 4.084

Review 9.  Aeroallergens in Canada: Distribution, Public Health Impacts, and Opportunities for Prevention.

Authors:  Cecilia Sierra-Heredia; Michelle North; Jeff Brook; Christina Daly; Anne K Ellis; Dave Henderson; Sarah B Henderson; Éric Lavigne; Tim K Takaro
Journal:  Int J Environ Res Public Health       Date:  2018-07-25       Impact factor: 3.390

10.  Characterization of Patients with Allergic Rhinitis to Ragweed Pollen in Two Distinct Regions of Romania.

Authors:  Ioana Corina Bocsan; Ioana Adriana Muntean; Corina Ureche; Raluca Maria Pop; Maria Adriana Neag; Octavia Sabin; Diana Deleanu; Anca Dana Buzoianu
Journal:  Medicina (Kaunas)       Date:  2019-10-24       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.